For CABG patients with Afib, the data supporting treatment is growing stronger. Epicardial ablation is associated with superior long-term survival. LAAO is associated with meaningfully lower stroke risk and lower bleeding readmissions. It doesn't have to be one or the other. Together, they offer patients the most complete approach to Afib management during CABG procedures. One operation. One opportunity. These patients deserve both. Learn more: https://okt.to/9IO7qU #CABG #SurgicalAblation #LAAManagementhttps://bit.ly/4zemORy
AtriCure, Inc.
Medical Equipment Manufacturing
Mason, Ohio 52,497 followers
We are passionately focused on healing the lives of those affected by Afib and pain after surgery.
About us
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
- Website
-
http://www.atricure.com
External link for AtriCure, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Mason, Ohio
- Type
- Public Company
- Founded
- 2000
- Specialties
- Medical Devices, Manufacturing, Atrial Fibrillation, and Maze IV Training
Locations
Employees at AtriCure, Inc.
Updates
-
More than 500,000 hours of development, innovation, testing and refinement across three generations have shaped the AtriClip portfolio into what it is today. The result is a solution that is trusted to deliver consistent, dependable outcomes alongside an unwavering commitment to enhancing the standard of patient care. Learn more: https://okt.to/YBwSJf #AtriClip #LAAExclusion #CardiacSurgery
-
-
Surgical outcomes are about more than just the procedure. Pain and discomfort can overshadow results, changing the way patients perceive their experience. Cryo Nerve Block provides an opportunity to proactively manage post-op pain, supporting a stronger recovery journey. The recovery process should reflect the same standard of care given during surgery. Learn more about Cryo Nerve Block: https://okt.to/zPj0nY #PainManagement #cryoNB
-
-
Advancing care starts with asking the right questions. The BoxX-NoAF clinical trial is studying whether surgical ablation and LAA exclusion during cardiac surgery can help prevent new-onset post-op Afib (POAF) in patients with risk factors but no prior history of Afib. Better patient outcomes start with prevention, not just treatment. Learn more about the study at: https://okt.to/ABfi2M #ClinicalTrial #Afib #CardiacSurgery
-
-
It’s time to stop accepting post-amputation pain as the norm. The cryoXT™ probe gives surgeons the opportunity to proactively manage post-amputation pain by freezing the pain signals at the time of the procedure. Learn more about the cryoXT™ probe: https://okt.to/g1BUCr #PainManagement #Amputation #VascSurg
-
From one generation to the next, the AtriClip portfolio has evolved through continuous innovation and purposeful design to deliver reliable results that surgeons and patients can trust. Learn more about the AtriClip portfolio: https://okt.to/OFxGn3 #AtriClip #LAAExclusion #CardiacSurgery
-
A milestone worth celebrating. Dr. Marcelo C. DaSilva, MD, FACS, FICS, Dr. Gary Chmielewski, Dr. Colleen Gaughan, MD and Dr. Brandon Hendricksen together from AdventHealth have now treated 1,000+ patients with cardiothoracic Cryo Nerve Block. By integrating cardiothoracic cryoNB into their surgical workflow, the team is helping patients better manage post-operative pain. Improved post-op pain control can help support recovery through better respiratory function, earlier mobility, and a more comfortable recovery experience. Learn more: https://okt.to/nDce7u #PainManagement #cryoNB
-
-
Adding surgical ablation to a cardiac procedure shouldn't feel like a separate operation. Designed to work within the existing workflow, the Isolator® Synergy™ EnCompass® clamp offers minimal dissection with a non-atriotomy approach by traveling through the heart's natural sinuses. The result: a robust transmural ablation in a single application. Learn more about how you can incorporate EnCompass into your procedures: https://okt.to/9E1qSH #SurgicalAblation #CardiacSurgery
-
For patients with Afib, hybrid ablation may improve long-term rhythm outcomes. A meta-analysis of more than 400 patients across three randomized trials found that hybrid ablation was associated with a 27% reduction in arrhythmia recurrence and superior maintenance of normal sinus rhythm at 1 year versus non-hybrid approaches. Learn more: https://lnkd.in/g3Y6MbEK
-
Confidence is built from results. Designed for permanent LAA exclusion, the AtriClip Mini delivers secure, reliable results surgeons can count on. Learn more about the AtriClip Mini: https://okt.to/n51Md7 #AtriClip #LAAExclusion #CardiacSurgery